Comparing Oak Street Health (OSH) & The Competition

Oak Street Health (NYSE:OSHGet Rating) is one of 33 publicly-traded companies in the “Health services” industry, but how does it compare to its rivals? We will compare Oak Street Health to similar companies based on the strength of its dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Valuation & Earnings

This table compares Oak Street Health and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Oak Street Health $1.43 billion -$409.40 million -8.91
Oak Street Health Competitors $1.36 billion -$98.47 million 28.41

Oak Street Health has higher revenue, but lower earnings than its rivals. Oak Street Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Oak Street Health has a beta of 2.32, meaning that its share price is 132% more volatile than the S&P 500. Comparatively, Oak Street Health’s rivals have a beta of 1.48, meaning that their average share price is 48% more volatile than the S&P 500.

Institutional and Insider Ownership

91.3% of Oak Street Health shares are owned by institutional investors. Comparatively, 47.2% of shares of all “Health services” companies are owned by institutional investors. 11.4% of Oak Street Health shares are owned by insiders. Comparatively, 22.1% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Oak Street Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Oak Street Health -26.04% -1,883.59% -26.05%
Oak Street Health Competitors -325.87% -481.74% -38.64%

Analyst Ratings

This is a summary of recent recommendations and price targets for Oak Street Health and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oak Street Health 1 5 7 0 2.46
Oak Street Health Competitors 7 128 274 0 2.65

Oak Street Health currently has a consensus target price of $30.87, indicating a potential upside of 52.58%. As a group, “Health services” companies have a potential upside of 122.82%. Given Oak Street Health’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Oak Street Health has less favorable growth aspects than its rivals.

Summary

Oak Street Health rivals beat Oak Street Health on 7 of the 12 factors compared.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.